ENTITY
Legend Biotech Corp

Legend Biotech Corp (LEGN US)

100
Analysis
Health Care • China
Legend Biotech Corporation operates as a biopharmaceutical company. The Company engages in discovery and development of novel cell therapies for oncology and other indications. Legend Biotech serves customers in the State of New Jersey.
more
bullish•JW Therapeutics
•28 Oct 2020 09:35

JW Therapeutics - Concerns Are in the Short Term but Still Promising in the Long Term

This article analyzed the concerns (market size, high cost, financial performance, etc.) for JW Therapeutics in the short run but also include...

Logo
496 Views
Share
bearish•Li Auto
•31 Jul 2020 14:35

Li Auto (ē†ęƒ³ę±½č½¦) Trading Update - No Mention of Hillhouse's Investment

Li Auto Inc. (LI US) raised about US$1.1bn at US$11.50 per share, above the top-end of its IPO price range last night. We have covered the deal in...

Share
bearish•Immunotech Biopharm
•23 Jun 2020 15:57

Immunotech Biopharm (ę°øę³°ē”Ÿē‰©) IPO: Behind the Curve in Cell Therapy

Immunotech Biopharma, a cell therapy focused healthcare company, launched book building to raise up to USD 142 million to list in Hong Kong. In our...

Logo
774 Views
Share
bullish•JD.com (ADR)
•07 Jun 2020 12:14

ECM Weekly (7 June 2020) - JD & NetEase HK Bookbuild, Burning Rock & Nongfu Spring Valuation

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong Kong...

Share
bullish•Legend Biotech Corp
•05 Jun 2020 16:20

Legend Biotech (ä¼ å„‡ē”Ÿē‰©) IPO Trading: +27% Upside from Pricing

Legend Biotech, a leading CAR-T player, priced at USD 23/ADS and raised USD 423 million. The stock will start trading today. In this note, we will...

Logo
498 Views
Share
x